| |
| |
|
| Insider
Information: |
Miller Steve |
| Relationship: |
Chief Op. & Scientific... |
| City: |
Coral Gables |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
825,124 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,286,096 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
825,124 |
|
|
| Total
Value |
$12,286,096 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
| Percentage
Gain/Loss : |
0.0%
|
 44.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Catalyst Pharmaceutical Partners... |
CPRX |
Chief Op. & Scientific... |
2024-02-15 |
825,124 |
2008-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CPRX |
Catalyst Pharmaceutical P... |
Chief Op. & Scientific Officer |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,667 |
825,124 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Op. & Scientific Officer |
• – – |
2023-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
811,457 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Op. & Scientific Officer |
• – – |
2023-12-11 |
4 |
OE |
$1.13 |
$169,500 |
D/D |
150,000 |
797,457 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Op. & Scientific Officer |
• – – |
2023-12-05 |
4 |
S |
$14.24 |
$569,600 |
D/D |
(40,000) |
647,457 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2023-05-11 |
4 |
OE |
$0.79 |
$79,000 |
D/D |
100,000 |
687,457 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,666 |
587,457 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
573,791 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-11-23 |
4 |
S |
$17.34 |
$346,740 |
D/D |
(20,000) |
553,791 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-11-21 |
4 |
S |
$15.28 |
$1,222,080 |
D/D |
(80,000) |
573,791 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-09-13 |
4 |
S |
$16.85 |
$1,824,367 |
D/D |
(107,933) |
653,791 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-08-18 |
4 |
S |
$13.43 |
$2,029,922 |
D/D |
(150,000) |
761,724 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2022-08-18 |
4 |
OE |
$2.53 |
$379,500 |
D/D |
150,000 |
793,149 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2021-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
761,724 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2021-08-25 |
4 |
S |
$5.56 |
$444,640 |
D/D |
(80,000) |
741,724 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2021-08-25 |
4 |
OE |
$3.12 |
$374,400 |
D/D |
120,000 |
821,724 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2021-08-13 |
4 |
S |
$6.09 |
$249,416 |
D/D |
(40,963) |
701,724 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2021-08-13 |
4 |
OE |
$3.12 |
$202,800 |
D/D |
65,000 |
742,687 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2020-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
677,687 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2017-11-06 |
4 |
OE |
$0.47 |
$94,000 |
D/D |
200,000 |
657,687 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2016-01-11 |
4 |
B |
$1.80 |
$14,279 |
D/D |
7,933 |
457,687 |
2.74 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2015-08-25 |
4 |
OE |
$1.09 |
$65,400 |
D/D |
60,000 |
449,754 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2014-10-02 |
4 |
OE |
$0.90 |
$157,500 |
D/D |
175,000 |
389,754 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2014-06-04 |
4 |
B |
$2.17 |
$216,990 |
D/D |
100,000 |
214,754 |
2.74 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Operating Officer |
• – – |
2012-07-03 |
4 |
B |
$0.55 |
$21,951 |
D/D |
40,000 |
114,754 |
2.74 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP Development & Management |
• – – |
2008-01-01 |
4 |
A |
$3.01 |
$5,400 |
D/D |
1,794 |
74,754 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
